Geographic Disparity of Outcome in Patients With Cancer Over Decades: The Surveillance, Epidemiology, and End Results

This publication has 17 references indexed in Scilit:

• Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
  Journal of Clinical Oncology, 2016
• Analysis of 2013 European LeukaemiaNet (ELN) responses in chronic phase CML across four frontline TKI modalities and impact on clinical outcomes
  British Journal of Haematology, 2016
• Conditional survival in patients with chronic myeloid leukemia in chronic phase in the era of tyrosine kinase inhibitors
  Cancer, 2015
• Relative survival in patients with chronic-phase chronic myeloid leukaemia in the tyrosine-kinase inhibitor era: analysis of patient data from six prospective clinical trials
  The Lancet Haematology, 2015
• Long-term molecular and cytogenetic response and survival outcomes with imatinib 400 mg, imatinib 800 mg, dasatinib, and nilotinib in patients with chronic-phase chronic myeloid leukaemia: retrospective analysis of patient data from five clinical trials
  The Lancet Haematology, 2015
• Does stage at diagnosis influence the observed relationship between socioeconomic status and breast cancer incidence, case-fatality, and mortality?
  Social Science & Medicine, 2003
• Cancer Survival in Kentucky and Health Insurance Coverage
  Archives of internal medicine (1960), 2003
• An International Comparison of Breast Cancer Survival
  Annals of Epidemiology, 2003
• Associations Between Community Income and Cancer Survival in Ontario, Canada, and the United States
  Journal of Clinical Oncology, 1999
• An International Comparison of Cancer Survival: Advantage of Toronto’s Poor Over the Near Poor of Detroit
  Canadian Journal of Public Health, 1998